Asia Pacific Stem Cell Therapy Market Size Expands at Significant CAGR of 10.48% to Surpass USD 5 Billion by 2030
Asia Pacific Stem Cell Therapy Market is experiencing significant momentum due to the adoption of swift technological advancements and an increasing demand for stem cell therapy across the region.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Stem Cell Therapy Market size at USD 2.76 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Stem Cell Therapy Market size to grow at a CAGR of 10.48% reaching a value of USD 5.02 billion by 2030. The Asia Pacific Stem Cell Therapy Market is primarily driven by increasing investments in research and development of effective therapies to treat rising prevalence of chronic diseases and growing awareness about the therapeutic potential of stem cells. Advancements in healthcare infrastructure, a surge in government initiatives, and the expanding elderly population contribute to market growth. Additionally, collaborations between research institutions and pharmaceutical companies, coupled with favorable regulatory frameworks, propel the adoption of stem cell therapies. The region's robust biotechnology sector and the pursuit of innovative treatment options further stimulate market expansion, fostering a conducive environment for advancements in stem cell therapy across diverse medical applications.
Opportunity – Development of personalized stem cell therapies
In the dynamic landscape of the Asia Pacific Stem Cell Therapy Market, the advent of personalized stem cell therapies emerges as a formidable growth driver. The innovative approach of stem cell therapies tailors treatments to individual patients, unlocking unprecedented potential for targeted and effective medical solutions. With a focus on precision medicine, the development of stem cell therapies not only enhances patient outcomes but also accelerates the market expansion, marking a paradigm shift in regenerative medicine across the Asia Pacific region.
Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market
On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. In response to this global health crisis, researchers have been actively pursuing innovative cures and treatments. Recent years have demonstrated the efficacy of stem cell therapy in treating respiratory conditions, particularly COVID-19. The official international registry for clinical trials has recorded at least 10 projects focused on utilizing mesenchymal stem cells to treat patients with coronavirus pneumonia. The surge in research and clinical trials has led to an increased demand for stem cell therapy, consequently boosting the growth of Stem Cell Therapy Market.
Asia Pacific Stem Cell Therapy Market
Segmental Coverage
Asia Pacific Stem Cell Therapy Market – By Type
Based on type, Asia Pacific Stem Cell Therapy Market is divided into Autologous and Allogeneic segments. Autologous stem cell therapy involves using a patient's cells for treatment, offering personalized and efficient solutions. The segment's prominence reflects the region's growing focus on personalized medicine and the potential for enhanced therapeutic outcomes through patient-specific treatments. Allogeneic stem cell therapy, which uses cells from a donor, also contributes to the market, catering to specific medical needs. However, the dominance of the autologous segment underscores the demand for tailored healthcare solutions in the Asia Pacific region.
Asia Pacific Stem Cell Therapy Market – By Cell Source
By cell source, Asia Pacific Stem Cell Therapy Market is divided into Adipose Tissue-derived, MSC, Bone Marrow, and Placenta/Umbilical Cord segments. The mesenchymal stem cells (MSC) segment is the largest cell source in the Asia Pacific Stem Cell Therapy Market. MSCs have gained prominence due to their versatility in differentiation and therapeutic applications, contributing significantly to the region's stem cell therapy market. With widespread research and clinical applications, MSCs stand out as the leading segment, reflecting their pivotal role in advancing regenerative medicine across diverse medical fields in the Asia Pacific region.
Competitive Landscape
Asia Pacific Stem Cell Therapy Market is fiercely competitive. Major companies in the market include Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, Medipost Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, and Mesoblast Ltd. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Stem Cell Therapy Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Asia Pacific Stem Cell Therapy Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Asia Pacific Stem Cell Therapy Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Asia Pacific Stem Cell Therapy Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising prevalence of chronic diseases
- 3.2.1.2. Growing awareness of stem cell therapy
- 3.2.2. Restraints
- 3.2.2.1. High cost of stem cell therapy
- 3.2.2.2. Lack of regulation and standardization:
- 3.2.3. Opportunities
- 3.2.3.1. Development of personalized stem cell therapies:
- 3.2.3.2. Expansion into new therapeutic areas:
- 3.2.4. Challenges
- 3.2.4.1. Limited clinical data:
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Asia Pacific Stem Cell Therapy Market Overview
- 4.1. Market Size & Forecast by Value & Volume, 2019–2030
- 4.1.1. By Value (USD Billion)
- 4.2. Market Share & Forecast
- 4.2.1. By Type
- 4.2.1.1. Autologous
- 4.2.1.2. Allogeneic
- 4.2.2. By Cell Source
- 4.2.2.1. Adipose Tissue-Derived
- 4.2.2.2. MSC
- 4.2.2.3. Bone Marrow
- 4.2.2.4. Placenta/Umbilical Cord
- 4.2.3. By Application
- 4.2.3.1. Musculoskeletal
- 4.2.3.2. Wounds
- 4.2.3.3. Surgeries
- 4.2.3.4. Cardiovascular
- 4.2.3.5. Neurological
- 4.2.4. By End User
- 4.2.4.1. Hospitals & Clinics
- 4.2.4.2. Academic & Research Institutes
- 4.2.5. By Country
- 4.2.5.1. China
- 4.2.5.2. India
- 4.2.5.3. Japan
- 4.2.5.4. South Korea
- 4.2.5.5. Australia & New Zealand
- 4.2.5.6. Indonesia
- 4.2.5.7. Malaysia
- 4.2.5.8. Singapore
- 4.2.5.9. Vietnam
- 4.2.5.10. Rest of APAC
- 5. China Stem Cell Therapy Market Overview
- 5.1. Market Size & Forecast by Value & Volume, 2019–2030
- 5.1.1. By Value (USD Billion)
- 5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By Cell Source
- 5.2.3. By Application
- 5.2.4. By End User
- 6. India Stem Cell Therapy Market Overview
- 6.1. Market Size & Forecast by Value & Volume, 2019–2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Cell Source
- 6.2.3. By Application
- 6.2.4. By End User
- 7. Japan Stem Cell Therapy Market Overview
- 7.1. Market Size & Forecast by Value & Volume, 2019–2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Cell Source
- 7.2.3. By Application
- 7.2.4. By End User
- 8. South Korea Stem Cell Therapy Market Overview
- 8.1. Market Size & Forecast by Value & Volume, 2019–2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Cell Source
- 8.2.3. By Application
- 8.2.4. By End User
- 9. Australia & New Zealand Stem Cell Therapy Market Overview
- 9.1. Market Size & Forecast by Value & Volume, 2019–2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Cell Source
- 9.2.3. By Application
- 9.2.4. By End User
- 10. Indonesia Stem Cell Therapy Market Overview
- 10.1. Market Size & Forecast by Value & Volume, 2019–2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Cell Source
- 10.2.3. By Application
- 10.2.4. By End User
- 11. Malaysia Stem Cell Therapy Market Overview
- 11.1. Market Size & Forecast by Value & Volume, 2019–2030
- 11.1.1. By Value (USD Billion)
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Cell Source
- 11.2.3. By Application
- 11.2.4. By End User
- 12. Singapore Stem Cell Therapy Market Overview
- 12.1. Market Size & Forecast by Value & Volume, 2019–2030
- 12.1.1. By Value (USD Billion)
- 12.2. Market Share & Forecast
- 12.2.1. By Type
- 12.2.2. By Cell Source
- 12.2.3. By Application
- 12.2.4. By End User
- 13. Vietnam Stem Cell Therapy Market Overview
- 13.1. Market Size & Forecast by Value & Volume, 2019–2030
- 13.1.1. By Value (USD Billion)
- 13.2. Market Share & Forecast
- 13.2.1. By Type
- 13.2.2. By Cell Source
- 13.2.3. By Application
- 13.2.4. By End User
- 14. Rest of APAC Stem Cell Therapy Market Overview
- 14.1. Market Size & Forecast by Value & Volume, 2019–2030
- 14.1.1. By Value (USD Billion)
- 14.2. Market Share & Forecast
- 14.2.1. By Type
- 14.2.2. By Cell Source
- 14.2.3. By Application
- 14.2.4. By End User
- 15. Competitive Landscape
- 15.1. List of Key Players and Their Offerings
- 15.2. Asia Pacific Stem Cell Therapy Company Market Share Analysis, 2023
- 15.3. Competitive Benchmarking, By Operating Parameters
- 15.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
- 16. Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market
- 17. Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market
- 18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 18.1. Bristol Myers Squibb Company
- 18.2. Gilead Sciences Inc
- 18.3. JCR Pharmaceuticals Co Ltd,
- 18.4. Kolon TissueGene Inc
- 18.5. MEDIPOST Co Ltd,
- 18.6. Smith & Nephew Plc,
- 18.7. Vericel Corporation
- 18.8. Takeda Pharmaceutical Company Limited
- 18.9. Mesoblast Ltd
- 18.10. Other Prominent Players
- 19. Key Strategic Recommendations
- 20. Research Methodology
- 20.1. Qualitative Research
- 20.1.1. Primary & Secondary Research
- 20.2. Quantitative Research
- 20.3. Market Breakdown & Data Triangulation
- 20.3.1. Secondary Research
- 20.3.2. Primary Research
- 20.4. Breakdown of Primary Research Respondents, By Region
- 20.5. Assumption & Limitation
- *Financial information of non-listed companies will be provided as per availability
- **The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
- List of Figures
- Figure 1 Asia Pacific Stem Cell Therapy Market Segmentation
- Figure 2 Asia Pacific Stem Cell Therapy Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 5 Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 6 Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 7 Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 8 Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 9 Asia Pacific Stem Cell Therapy Market Share, By Country, By Value, 2019–2030
- Figure 10 China Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 11 China Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 12 China Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 13 China Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 14 China Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 15 India Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 16 India Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 17 India Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 18 India Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 19 India Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 20 Japan Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 21 Japan Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 22 Japan Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 23 Japan Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 24 Japan Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 25 South Korea Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 26 South Korea Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 27 South Korea Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 28 South Korea Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 29 South Korea Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 30 Australia & New Zealand Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 31 Australia & New Zealand Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 32 Australia & New Zealand Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 33 Australia & New Zealand Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 34 Australia & New Zealand Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 35 Indonesia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 36 Indonesia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 37 Indonesia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 38 Indonesia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 39 Indonesia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 40 Malaysia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 41 Malaysia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 42 Malaysia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 43 Malaysia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 44 Malaysia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 45 Singapore Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 46 Singapore Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 47 Singapore Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 48 Singapore Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 49 Singapore Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 50 Vietnam Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 51 Vietnam Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 52 Vietnam Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 53 Vietnam Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 54 Vietnam Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- Figure 55 Rest of Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
- Figure 56 Rest of Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
- Figure 57 Rest of Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
- Figure 58 Rest of Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
- Figure 59 Rest of Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
- List of Tables
- Table 1 Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 2 Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 3 Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 4 Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 5 Asia Pacific Stem Cell Therapy Market Size, By Country, By Value, 2019–2030
- Table 6 China Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 7 China Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 8 China Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 9 China Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 10 India Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 11 India Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 12 India Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 13 India Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 14 Japan Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 15 Japan Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 16 Japan Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 17 Japan Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 18 South Korea Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 19 South Korea Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 20 South Korea Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 21 South Korea Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 22 Australia & New Zealand Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 23 Australia & New Zealand Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 24 Australia & New Zealand Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 25 Australia & New Zealand Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 26 Indonesia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 27 Indonesia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 28 Indonesia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 29 Indonesia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 30 Malaysia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 31 Malaysia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 32 Malaysia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 33 Malaysia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 34 Singapore Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 35 Singapore Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 36 Singapore Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 37 Singapore Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 38 Vietnam Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 39 Vietnam Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 40 Vietnam Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 41 Vietnam Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 42 Rest of Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
- Table 43 Rest of Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
- Table 44 Rest of Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
- Table 45 Rest of Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
- Table 46 Bristol Myers Squibb Company: Company Overview
- Table 47 Bristol Myers Squibb Company Financial Overview
- Table 48 Gilead Sciences Inc Company Overview
- Table 49 Gilead Sciences Inc Financial Overview
- Table 50 JCR Pharmaceuticals Co Ltd, Company Overview
- Table 51 JCR Pharmaceuticals Co Ltd, Financial Overview
- Table 52 Kolon TissueGene Inc Company Overview
- Table 53 Kolon TissueGene Inc Financial Overview
- Table 54 MEDIPOST Co Ltd, Company Overview
- Table 55 MEDIPOST Co Ltd, Financial Overview
- Table 56 Smith & Nephew Plc, Company Overview
- Table 57 Smith & Nephew Plc, Financial Overview
- Table 58 Vericel Corporation Company Overview
- Table 59 Vericel Corporation Financial Overview
- Table 60 Takeda Pharmaceutical Company Limited Company Overview
- Table 61 Takeda Pharmaceutical Company Limited Financial Overview
- Table 62 Mesoblast Ltd Company Overview
- Table 63 Mesoblast Ltd Financial Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook